Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Farde

Showing results (1-10 of 218) with videos related to

Pageof 22
Sort By:
CNS Neuroscience & Therapeutics|December 15, 2010
Antipsychotic occupancy of dopamine receptors in schizophreniaMagdalena Nord, Lars Farde
The International Journal of Neuropsychopharmacology|October 16, 2004
Half-life of receptor occupancy--a meaningless conceptHans Olsson, Lars Farde
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 16, 2015
Quantification of blood flow-dependent component in estimates of beta-amyloid load obtained using quasi-steady-state standardized uptake value ratioZsolt Cselényi, Lars Farde
Trends in Pharmacological Sciences|May 9, 2006
Using positron emission tomography to facilitate CNS drug developmentChi-Ming Lee, Lars Farde
Neuroimage|June 15, 2004
Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PETHans Olsson, Christer Halldin, Lars Farde
Imaging Neuroscience (Cambridge, Mass.)|August 13, 2025
Putative mapping of α-subunits in the human brain: A PET study of GABA <sub>A</sub> receptor bindingZsolt Cselényi, Aurelija Jucaite, Lars Farde
Psychopharmacology|October 24, 2012
SERT and NET occupancy by venlafaxine and milnacipran in nonhuman primates: a PET studyAkihiro Takano, Christer Halldin, Lars Farde
The International Journal of Neuropsychopharmacology|January 11, 2008
Age-related diurnal effect on D2 receptor binding: a preliminary PET studySimon Cervenka, Christer Halldin, Lars Farde
Synapse (New York, N.Y.)|June 6, 2006
Measurement of serotonin transporter binding with PET and [11C]MADAM: a test-retest reproducibility studyJohan Lundberg, Christer Halldin, Lars Farde
Journal of Pharmacokinetics and Pharmacodynamics|May 11, 2013
Modeling of PET data in CNS drug discovery and developmentKatarina Varnäs, Andrea Varrone, Lars Farde
Pageof 22

Showing results (1-10 of 218) with videos related to

Sort By:
Pageof 22
CNS Neuroscience & Therapeutics|December 15, 2010
Antipsychotic occupancy of dopamine receptors in schizophreniaMagdalena Nord, Lars Farde
The International Journal of Neuropsychopharmacology|October 16, 2004
Half-life of receptor occupancy--a meaningless conceptHans Olsson, Lars Farde
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 16, 2015
Quantification of blood flow-dependent component in estimates of beta-amyloid load obtained using quasi-steady-state standardized uptake value ratioZsolt Cselényi, Lars Farde
Trends in Pharmacological Sciences|May 9, 2006
Using positron emission tomography to facilitate CNS drug developmentChi-Ming Lee, Lars Farde
Neuroimage|June 15, 2004
Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PETHans Olsson, Christer Halldin, Lars Farde
Imaging Neuroscience (Cambridge, Mass.)|August 13, 2025
Putative mapping of α-subunits in the human brain: A PET study of GABA <sub>A</sub> receptor bindingZsolt Cselényi, Aurelija Jucaite, Lars Farde
Psychopharmacology|October 24, 2012
SERT and NET occupancy by venlafaxine and milnacipran in nonhuman primates: a PET studyAkihiro Takano, Christer Halldin, Lars Farde
The International Journal of Neuropsychopharmacology|January 11, 2008
Age-related diurnal effect on D2 receptor binding: a preliminary PET studySimon Cervenka, Christer Halldin, Lars Farde
Synapse (New York, N.Y.)|June 6, 2006
Measurement of serotonin transporter binding with PET and [11C]MADAM: a test-retest reproducibility studyJohan Lundberg, Christer Halldin, Lars Farde
Journal of Pharmacokinetics and Pharmacodynamics|May 11, 2013
Modeling of PET data in CNS drug discovery and developmentKatarina Varnäs, Andrea Varrone, Lars Farde
Pageof 22